Gabapentin
Product Images NDC 68788-8176

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68788-8176). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin Capsules 100mg (1e741495 A619 41e4 A466 0d2fb79df358 00)

Gabapentin Capsules 100mg are for patients who have been prescribed the medication and federal law prohibits the transfer of this drug to anyone else. Each capsule contains 100mg of gabapentin. It is a generic substitute for Neurontin. The capsules are white and should be stored at 20°-25°C (68°-77°F) with excursions permitted to -5°C. Keep the medication out of reach of children. The package size, expiration date, quantity plans, lot batch, and product number are indicated on the label. The manufacturer is Granules Pharmaceuticals Inc. and the product is for RX only. There is also information about a billing chart log.*

FDA Label Image

Gaba-fig-1-jpg.jpg (Gaba Fig 1 Jpg)

This is a chart displaying mean pain scores during a clinical trial for a medication. The trial had a 4-week dose titration period followed by a 4-week fixed dose period. The chart shows the mean pain scores for a placebo group and a group receiving 3600 mg/day of gabapentin at baseline, week 1, week 2, week 3, and week 4.*

FDA Label Image

Gaba-fig-2-jpg.jpg (Gaba Fig 2 Jpg)

This text describes a clinical trial that involves giving patients different doses of gabapentin (1800 mg/day or 2400 mg/day) or a placebo over a period of 4 weeks. The pain scores of the patients are recorded before and after the treatment. However, there is not enough information to determine the extent or type of pain that is being treated, the size or demographics of the study population or any conclusions drawn from the study.*

FDA Label Image

Gaba-fig-3-jpg.jpg (Gaba Fig 3 Jpg)

The text appears to be a table or a figure showing the proportion of responders with more than 50% reduction in pain score in a study or studies related to controlled PHN. It also includes some values related to GBP (Great Britain Pound). Without further context, it is difficult to interpret the data presented.*

FDA Label Image

Gaba-fig-4-jpg.jpg (Gaba Fig 4 Jpg)

FDA Label Image

Gaba-structure.jpg (Gaba Structure)

FDA Label Image

Gabapentin-formula-jpg.jpg (Gabapentin Formula Jpg)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.